2024
Combined interventions for the testing and treatment of HIV and schistosomiasis among fishermen in Malawi: a three-arm, cluster-randomised trial
Choko A, Dovel K, Kayuni S, Conserve D, Buttterworth A, Bustinduy A, Stothard J, Kamchedzera W, Mukoka-Thindwa M, Jafali J, MacPherson P, Fielding K, Desmond N, Corbett E. Combined interventions for the testing and treatment of HIV and schistosomiasis among fishermen in Malawi: a three-arm, cluster-randomised trial. The Lancet Global Health 2024, 12: e1673-e1683. PMID: 39304239, PMCID: PMC11420466, DOI: 10.1016/s2214-109x(24)00283-3.Peer-Reviewed Original ResearchConceptsVoluntary male medical circumcisionHIV self-test kitsCluster randomised trialSelf-test kitsPeer educatorsDistribution of HIV self-testing kitsIncrease uptake of ARTSOC groupUptake of antiretroviral therapyThree-armEnhanced standard of careAntiretroviral therapyRisk ratioNational Institute for Health ResearchHard-to-reach communitiesMale medical circumcisionUK National Institute for Health ResearchStandard of careProportion of participantsIntracluster correlation coefficientPE groupComputer-generated random numbersActive schistosomiasisUndiagnosed HIVAntiretroviral therapy initiation
2023
Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses
Collaboration E, Sofianopoulou E, Kaptoge S, Afzal S, Jiang T, Gill D, Gundersen T, Bolton T, Allara E, Arnold M, Mason A, Chung R, Pennells L, Shi F, Sun L, Willeit P, Forouhi N, Langenberg C, Sharp S, Panico S, Engström G, Melander O, Tong T, Perez-Cornago A, Norberg M, Johansson I, Katzke V, Srour B, Sánchez M, Redondo-Sánchez D, Olsen A, Dahm C, Overvad K, Brustad M, Skeie G, Moreno-Iribas C, Onland-Moret N, van der Schouw Y, Tsilidis K, Heath A, Agnoli C, Krogh V, de Boer I, Kobylecki C, Çolak Y, Zittermann A, Sundström J, Welsh P, Weiderpass E, Aglago E, Ferrari P, Clarke R, Boutron M, Severi G, MacDonald C, Providencia R, Masala G, Zamora-Ros R, Boer J, Verschuren M, Cawthon P, Schierbeck L, Cooper C, Schulze M, Bergmann M, Hannemann A, Kiechl S, Brenner H, van Schoor N, Albertorio J, Sacerdote C, Linneberg A, Kårhus L, Huerta J, Imaz L, Joergensen C, Ben-Shlomo Y, Lundqvist A, Gallacher J, Sattar N, Wood A, Wareham N, Nordestgaard B, Di Angelantonio E, Danesh J, Butterworth A, Burgess S. Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. The Lancet Diabetes & Endocrinology 2023, 12: e2-e11. PMID: 38048800, PMCID: PMC7615586, DOI: 10.1016/s2213-8587(23)00287-5.Peer-Reviewed Original ResearchConceptsMendelian randomisation analysisCoronary heart diseaseRandomisation analysesAll-Cause MortalityMortality outcomesFatal ischaemic heart diseaseHeart diseaseIncident coronary heart diseaseHistory of coronary heart diseasePopulation-based cohort studyHealth Data Research UKCause-specific mortality outcomesNational Institute for Health ResearchMendelian randomisation frameworkDose-response relationshipIndividuals of European ancestryRisk of coronary heart diseaseRandomised trials of vitamin D supplementationLow vitamin D statusBritish Heart FoundationCancer Research UKInternational Agency for Research on CancerMiddle-aged individualsIschaemic heart diseaseMedical Research Council
2022
Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis
Li J, Luo J, Pavlov I, Perez Y, Tan W, Roca O, Tavernier E, Kharat A, McNicholas B, Ibarra-Estrada M, Vines D, Bosch N, Rampon G, Simpson S, Walkey A, Fralick M, Verma A, Razak F, Harris T, Laffey J, Guerin C, Ehrmann S, Group A, Li J, Luo J, Pavlov I, Perez Y, Tan W, Roca O, Tavernier E, Kharat A, McNicholas B, Ibarra-Estrada M, Vines D, Bosch N, Rampon G, Simpson S, Walkey A, Fralick M, Verma A, Razak F, Harris T, Laffey J, Guerin C, Ehrmann S, Mirza S, Xue L, Pavord I, Plamondon P, Jayaraman D, Shahin J, Dahine J, Kulenkamp A, Pacheco A. Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis. The Lancet Respiratory Medicine 2022, 10: 573-583. PMID: 35305308, PMCID: PMC8926412, DOI: 10.1016/s2213-2600(22)00043-1.Peer-Reviewed Original ResearchConceptsAcute hypoxaemic respiratory failureHypoxaemic respiratory failureAwake prone positioningIntensive care unitAdvanced respiratory supportRespiratory failureNon-intubated patientsProne positionRespiratory supportRisk of biasObservational studySupine positionPrimary outcomeConventional oxygen therapyMeta-analysisPool individual studyPublished randomised controlled trialsIntensive care unit settingSystematic reviewNon-ICU settingsPaediatric patientsNational Institute for Health ResearchOxygen therapyBiomedical Research CentreOxford Biomedical Research Centre
2021
OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA)
Ugarte-Gil M, Alarcon G, Seet A, Izadi Z, Sokolova C, Clarke A, Wise L, Pons-Estel G, Santos M, Bernatsky S, Mathias L, Lim N, Sparks J, Wallace Z, Hyrich K, Strangfeld A, Gossec L, Carmona L, Mateus E, Lawson-Tovey S, Trupin L, Rush S, Schmajuk G, Katz P, Jacobsohn L, Al Emadi S, Gilbert E, Duarte-Garcia A, Valenzuela-Almada M, Hsu T, D'silva K, Serling-Boyd N, Dieudé P, Nikiphorou E, Kronzer V, Singh N, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann J, Liew J, Sirotich E, Sufka P, Robinson P, Machado P, Gianfrancesco M, Yazdany J, Alliance O. OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA). Annals Of The Rheumatic Diseases 2021, 80: 173-175. DOI: 10.1136/annrheumdis-2021-eular.2984.Peer-Reviewed Original ResearchSystemic lupus erythematosusChronic renal diseaseModerate/high disease activityNon-invasive ventilationSevere COVID-19 outcomesBristol-Myers SquibbDisease activityGrant/research supportRenal diseaseCOVID-19 outcomesCOVID-19 diagnosisDrug monotherapyImmunomodulatory therapyGlobal Rheumatology AllianceMembrane oxygenationCOVID-19 Global Rheumatology AllianceNational Institute for Health ResearchMale sexModerate to high daily dosesSLE adult patientsBristol-MyersSystemic lupus erythematosus patientsSystemic lupus erythematosus therapyCardiovascular diseaseOdds of poor outcome
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply